Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: -0.50 (-0.48%)
Spread: 3.00 (2.941%)
Open: 104.00
High: 104.00
Low: 103.50
Prev. Close: 104.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

21 Jan 2015 07:00

RNS Number : 7152C
Intercede Group PLC
21 January 2015
 



 

 

 

21 January 2015

 

INTERCEDE GROUP plc

('Intercede' or 'the Company')

 

Trading Update

 

 

Intercede (AIM: IGP.L) is a leading producer of Identity and Credential Management software, called MyID, which manages the secure registration, issuance and life cycle of digital identities for a wide range of uses.

At the time of reporting its Interim Results for the six months ended 30th September 2014 on 6 November 2014, Intercede remained optimistic that full year growth expectations would be achieved. However, the Company did state that this would be subject to the timing of certain orders, both from smart card related projects and from a number of mobile related opportunities.

As set out below, there have been a number of market related delays beyond the Company's control and, whilst revenues are expected to be greater in the second half of the current financial year than the first half, full year revenues are now anticipated to be at a similar level or slightly lower than the prior financial year.

In the US, two key standards FIPS 201-2 and SP800-157 were released and ratified more than three months later than anticipated thereby delaying the time to revenue of our MyID v10.1/v10.2 derived credential platform. The availability of TEE capability on OEM handsets has also been slower than anticipated thereby delaying the monetisation of the newly launched MyTAM service. In addition, a number of our existing customers are making slower progress than forecast on large scale modernisation projects incorporating our technology, resulting in delays in the receipt of follow on license orders.

The reduction in revenue expectations is expected to result in a loss for the period of approximately £1 million and year end cash balances, after planned investment and share buy-backs, in the region of £5 million.

Whilst the inevitable effect of the delays referred to above is a reduction in short term revenues, they do not structurally reduce the future demand for Intercede products nor do they impact the Company's strong growth prospects. We continue to experience high levels of interest in the Group's new mobile digital identity technology, which validates the potential scale of the opportunity for Intercede's products as people better understand the security implications of areas such as the Internet of Things, the Cloud, and the inherent limitations of usernames and passwords. Consequently, the Board remains confident in and committed to its chosen strategic course.

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

 

FinnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Joanna Weaving, Corporate Broking

 

 

Bell Pottinger Tel. +44 (0)7802 442486

Archie Berens

 

About IntercedeIntercede is a software company specializing in identity and credential management with a global team of experts located in the US and UK.

Intercede's MyID software enables organizations to create and use trusted digital identities for employees, citizens and machines. This allows secure access to services, facilities, information and networks.

MyID meets the highest government standards yet is simple enough to be deployed onto consumer devices such as smartphones and tablets. Critically, MyID provides an easy, convenient and secure alternative to passwords.

Millions of identities are managed using MyID and Intercede has provided identity verification and management services to global customers for more than 20 years. MyID is a commercial-off-the-shelf software product, designed and developed to be configurable so it can be embedded as the cornerstone of cybersecurity infrastructure for governments and corporations.

Customers trusting Intercede for secure digital identity include the US and UK governments and some of the world's largest corporations, telecommunications providers and information technology partners.

For more information visit www.intercede.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGSGDBLDDBGUB
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.